Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Gregory Gottschlich
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
17Publications signalées
1850Citations signalées
0Affiliations récentes
Domaines associés
Chronic Obstructive Pulmonary Disease (COPD) ResearchSARS-CoV-2 and COVID-19 ResearchInhalation and Respiratory Drug DeliveryAsthma and respiratory diseasesAllergic Rhinitis and Sensitization
Publications récentes
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals
Leigh H. Fisher, Jia Jin Kee, Albert Liu, Claudia Espinosa et autres
6 citationsJAMA Network Open
Risk of COVID-19 after natural infection or vaccination
Anne-Marie Rick, Matthew B. Laurens, Ying Huang, Chenchen Yu et autres
15 citationsEBioMedicine
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults
Deborah Theodore, Angela R Branche, Lily Zhang, Daniel S. Graciaa et autres
23 citationsJAMA Network Open
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
Domenica Rubino, Domenica Rubino, Niclas Abrahamsson, Melanie Davies et autres
1349 citationsJAMA
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Tim Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica et autres
179 citationsThe Lancet Respiratory Medicine
24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser et autres
16 citationsRespiratory Research
Corrigendum to “A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD” [Respir. Med. 120 November 2016 16–24]
Donald P. Tashkin, Fernando J. Martínez, Roberto Rodríguez-Roisin, Charles Fogarty et autres
4 citationsRespiratory Medicine
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson, Leonardo M. Fabbri et autres
106 citationsCHEST Journal
Beneficial Effect of GFF MDI: A LAMA/LABA FDC Delivered by MDI Using Novel Cosuspension Technology on Inspiratory Capacity in Patients With COPD
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser et autres
0 citationsCHEST Journal
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD
Donald P. Tashkin, Fernando J. Martínez, Roberto Rodríguez-Roisin, Charles Fogarty et autres
22 citationsRespiratory Medicine
Pooled analysis of 24-h lung function following treatment with the LAMA/LABA glycopyrronium/formoterol fumarate fixed-dose combination, delivered by a novel MDI co-suspension technology (GFF MDI), in COPD patients (pts)
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.